Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab
- Status
- UNKNOWN
- Phase
- PHASE4
Bevacizumab vs Dacarbazine in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)
- Status
- TERMINATED
- Phase
- PHASE2
Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV
- Status
- WITHDRAWN
- Phase
- PHASE2
Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye
- Status
- COMPLETED
- Phase
- PHASE3
Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
- Status
- UNKNOWN
- Phase
- N/A
Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery
- Status
- COMPLETED
- Phase
- PHASE2